XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash Flows From Operating Activities:    
Net loss $ (4,704,147) $ (4,336,309)
Adjustments to reconcile net loss to cash used in operating activities    
Change in fair value of warrant liability (858) (20,844)
Change in fair value of investment option liability (1,707) (19,165)
Stock-based compensation 400,108 721,102
Amortization of intangibles 42,180 84,376
Depreciation expense 78,824 85,812
Change in operating assets and liabilities:    
Prepaid expenses and other current assets 48,192 (543,822)
Accounts payable, accrued expenses and other current liabilities (11,300) (1,458,670)
Due to related parties (133,016)
Net cash used in operating activities (4,281,724) (5,487,520)
Cash Flows From Financing Activities:    
Proceeds from sale of Common Stock and warrants, net of offering costs 4,244,467
Proceeds from Common Stock sold for cash pursuant to the ATM Agreement, net 578,499
Proceeds from the exercise of warrants 75,044 2,676,980
Proceeds from the subscription receivable related to the issuance of Inducement Warrants and the exercise of warrants and preferred investment options 1,804,819
Proceeds from Common Stock sold under the Equity Distribution Agreement, net of offering costs 2,290,186
Proceeds from Common Stock sold under the Purchase Agreement, net of offering costs   82,026
Payment for offering costs previously accrued (161,312)
Net cash provided by financing activities 4,898,010 6,692,699
Effect of foreign exchange rate on changes on cash (7,496) 9,395
Net increase in cash 608,790 1,214,574
Cash at beginning of period 2,241,026 2,287,977
Cash at end of period 2,849,816 3,502,551
Supplemental disclosure of cash flow transactions:    
Cash paid for interest
Income taxes paid 24,001
Non-cash financing and investing activities:    
Non-cash issuance of round-up shares 874
Non-cash issuance of RSA vested shares 146
Offering costs accrued not paid 22,995 149
Issuance of common shares for offering costs 771,293
Deferred offering costs charged to offering costs $ 240,969